These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Shared epitope and anti-cyclic citrullinated peptide antibodies: relationship with age at onset and duration of disease in rheumatoid arthritis. Varadé J; Loza-Santamaría E; Fernández-Arquero M; Lamas JR; de Los Angeles Figueredo M; Jover JA; de la Concha EG; Rodríguez L; Urcelay E; Fernández-Gutiérrez B; Martínez-Doncel A J Rheumatol; 2009 May; 36(5):1085-6. PubMed ID: 19435975 [No Abstract] [Full Text] [Related]
3. Association of severe inflammatory polyarthritis in primary Sjögren's syndrome: clinical, serologic, and HLA analysis. Mohammed K; Pope J; Le Riche N; Brintnell W; Cairns E; Coles R; Bell DA J Rheumatol; 2009 Sep; 36(9):1937-42. PubMed ID: 19487261 [TBL] [Abstract][Full Text] [Related]
4. Emerging patterns of risk factor make-up enable subclassification of rheumatoid arthritis. van der Helm-van Mil AH; Huizinga TW; de Vries RR; Toes RE Arthritis Rheum; 2007 Jun; 56(6):1728-35. PubMed ID: 17534941 [No Abstract] [Full Text] [Related]
5. Regulation of anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis: contrasting effects of HLA-DR3 and the shared epitope alleles. Irigoyen P; Lee AT; Wener MH; Li W; Kern M; Batliwalla F; Lum RF; Massarotti E; Weisman M; Bombardier C; Remmers EF; Kastner DL; Seldin MF; Criswell LA; Gregersen PK Arthritis Rheum; 2005 Dec; 52(12):3813-8. PubMed ID: 16320316 [TBL] [Abstract][Full Text] [Related]
6. The genetics of rheumatic disease in man. Goldstein R; Arnett FC Rheum Dis Clin North Am; 1987 Dec; 13(3):487-510. PubMed ID: 3324202 [TBL] [Abstract][Full Text] [Related]
7. Smoking and HLA-DR shared epitope alleles in rheumatoid arthritis: comment on the article by Padyukov et al. Mattey DL; Hutchinson D Arthritis Rheum; 2005 Nov; 52(11):3675-6; author reply 3676-8. PubMed ID: 16258906 [No Abstract] [Full Text] [Related]
8. The HLA-DRB1 shared epitope alleles differ in the interaction with smoking and predisposition to antibodies to cyclic citrullinated peptide. van der Helm-van Mil AH; Verpoort KN; le Cessie S; Huizinga TW; de Vries RR; Toes RE Arthritis Rheum; 2007 Feb; 56(2):425-32. PubMed ID: 17265477 [TBL] [Abstract][Full Text] [Related]
9. Diagnostic value of anti-cyclic citrullinated peptide antibodies to detect rheumatoid arthritis in patients with Sjögren's syndrome. van Noord C; Hooijkaas H; Dufour-van den Goorbergh BC; van Hagen PM; van Daele PL; van de Merwe JP Ann Rheum Dis; 2005 Jan; 64(1):160-2. PubMed ID: 15608321 [No Abstract] [Full Text] [Related]
10. Every shared epitope allele for itself? van der Woude D; Huizinga TW Nat Rev Rheumatol; 2009 Sep; 5(9):477-8. PubMed ID: 19710670 [No Abstract] [Full Text] [Related]
11. Opposing effects of HLA-DRB1*13 alleles on the risk of developing anti-citrullinated protein antibody-positive and anti-citrullinated protein antibody-negative rheumatoid arthritis. Lundström E; Källberg H; Smolnikova M; Ding B; Rönnelid J; Alfredsson L; Klareskog L; Padyukov L Arthritis Rheum; 2009 Apr; 60(4):924-30. PubMed ID: 19333936 [TBL] [Abstract][Full Text] [Related]
12. Genetic background of anticyclic citrullinated peptide autoantibody production in Hungarian patients with rheumatoid arthritis. Poór G; Nagy ZB; Schmidt Z; Brózik M; Merétey K; Gergely P Ann N Y Acad Sci; 2007 Sep; 1110():23-32. PubMed ID: 17911417 [TBL] [Abstract][Full Text] [Related]
13. Influence of peptidylarginine deiminase type 4 genotype and shared epitope on clinical characteristics and autoantibody profile of rheumatoid arthritis. Hoppe B; Häupl T; Egerer K; Gruber R; Kiesewetter H; Salama A; Burmester GR; Dörner T Ann Rheum Dis; 2009 Jun; 68(6):898-903. PubMed ID: 18633125 [TBL] [Abstract][Full Text] [Related]
14. Quantitative heritability of anti-citrullinated protein antibody-positive and anti-citrullinated protein antibody-negative rheumatoid arthritis. van der Woude D; Houwing-Duistermaat JJ; Toes RE; Huizinga TW; Thomson W; Worthington J; van der Helm-van Mil AH; de Vries RR Arthritis Rheum; 2009 Apr; 60(4):916-23. PubMed ID: 19333951 [TBL] [Abstract][Full Text] [Related]
15. Autoantibodies in normals--the value of predicting rheumatoid arthritis. Dörner T; Hansen A Arthritis Res Ther; 2004; 6(6):282-4. PubMed ID: 15535841 [No Abstract] [Full Text] [Related]
16. Refining the complex rheumatoid arthritis phenotype based on specificity of the HLA-DRB1 shared epitope for antibodies to citrullinated proteins. Huizinga TW; Amos CI; van der Helm-van Mil AH; Chen W; van Gaalen FA; Jawaheer D; Schreuder GM; Wener M; Breedveld FC; Ahmad N; Lum RF; de Vries RR; Gregersen PK; Toes RE; Criswell LA Arthritis Rheum; 2005 Nov; 52(11):3433-8. PubMed ID: 16255021 [TBL] [Abstract][Full Text] [Related]
17. The HLA-DRB1 shared epitope is not associated with antibodies against cyclic citrullinated peptide in Chinese patients with rheumatoid arthritis. Xue Y; Zhang J; Chen YM; Guan M; Zheng SG; Zou HJ Scand J Rheumatol; 2008; 37(3):183-7. PubMed ID: 18465452 [TBL] [Abstract][Full Text] [Related]
18. Strong combined gene-environment effects in anti-cyclic citrullinated peptide-positive rheumatoid arthritis: a nationwide case-control study in Denmark. Pedersen M; Jacobsen S; Garred P; Madsen HO; Klarlund M; Svejgaard A; Pedersen BV; Wohlfahrt J; Frisch M Arthritis Rheum; 2007 May; 56(5):1446-53. PubMed ID: 17469102 [TBL] [Abstract][Full Text] [Related]
19. [Fibromyalgia--an artifact?]. Raspe H Z Rheumatol; 1996; 55(1):1-3. PubMed ID: 8868145 [No Abstract] [Full Text] [Related]
20. [Primary Sjögren syndrome. New concepts in the classification of the disease]. Font J; Coca A; Marine M; Ingelmo M; Balcells A Rev Clin Esp; 1982 Jan; 164(2):131-3. PubMed ID: 7089325 [No Abstract] [Full Text] [Related] [Next] [New Search]